• Dyslipidemia (elevated triglycerides, total, LDL, and non-HDL cholesterol; low HDL cholesterol); insulin resistance; diabetes should be recognized and minimized in adolescents with HIV infection |
• Lipid and other metabolic testing may not always be available as part of clinical care |
• The major goal should be to minimize abnormalities through nonpharmacologic means and in accordance with established guidelines for non-HIV-infected adolescents and HIV-infected adults |
• Low-fat diets alone are not the optimal way of minimizing lipid abnormalities; intake of simple sugars should also be minimized |
• Pharmacologic management of diabetes and dyslipidemia should be performed in accordance with established guidelines for HIV-infected adults and for non-HIV-infected children and adolescents |